Nexien BioPharma, Inc. (NXEN)

OTCMKTS · Delayed Price · Currency is USD
0.0060
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Market Cap403.40K
Revenue (ttm)n/a
Net Income (ttm)-188.08K
Shares Out70.77M
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,186
Average Volume2,162
Open0.0057
Previous Close0.0060
Day's Range0.0057 - 0.0060
52-Week Range0.0041 - 0.0495
Beta-0.80
RSI44.15
Earnings DateSep 26, 2025

About HashiCorp

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado. [Read more]

Sector Healthcare
CEO Richard Greenberg
Country United States
Stock Exchange OTCMKTS
Ticker Symbol NXEN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.